Cart
sales@molnova.com
Ralfinamide mesylate
CAS No. 202825-45-4
Ralfinamide mesylate( FCE-26742A (mesylate) )
Catalog No. M20790 CAS No. 202825-45-4
Ralfinamide mesylate is an orally available Na+ channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 181 | In Stock |
|
| 5MG | 115 | In Stock |
|
| 10MG | 180 | In Stock |
|
| 25MG | 296 | In Stock |
|
| 50MG | 384 | In Stock |
|
| 100MG | 542 | In Stock |
|
| 200MG | 728 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRalfinamide mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionRalfinamide mesylate is an orally available Na+ channel blocker.
-
DescriptionRalfinamide mesylate is an orally available Na+ channel blocker.
-
In Vitro——
-
In VivoRalfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain. Animal Model:81 adult male Sprague–Dawley male rats (260–460 g) Dosage:80 mg/kg (7 days preoperatively), 30 mg/kg, 60 mg/kg (postoperative)Administration:Oral gavage; twice daily; until postoperative day 42 Result:Suppressed neuropathic pain.
-
SynonymsFCE-26742A (mesylate)
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202825-45-4
-
Formula Weight398.45
-
Molecular FormulaC18H23FN2O5S?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O.CS(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liang X Yu G Su R . Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain[J]. European journal of pharmacology 2018 823:27-34.
molnova catalog
related products
-
QX-222 chloride
QX222 is a sodium channel blocker.
-
Huwentoxin IV
Selective NaV1.7 channel blocker. Preferentially inhibits neuronal NaV1.7, 1.2 and 1.3 (IC50 values are 26, 150 and 338 nM respectively), compared to muscle subtypes NaV1.4 and 1.5 (IC50 = >10 μM). Inhibits the channel by binding at the neurotoxin receptor site 4 in the S3-S4 linker of domain II, trapping the voltage sensor in the inward, closed configuration.
-
Allocryptopine
Allocryptopine induces muscle contraction and relaxation in urinary bladder and ileum, respectively.
